2003
DOI: 10.1002/jbm.a.10896
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of polyurethane valve cusp calcification with covalently attached bisphosphonate diethylamino moieties

Abstract: DBP polyurethane possesses physical (water absorption) and biomechanical properties comparable to unmodified polyurethane and can resist intrinsic heart-valve leaflet calcification in blood-stream implants.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
33
0

Year Published

2003
2003
2012
2012

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 41 publications
(34 citation statements)
references
References 35 publications
1
33
0
Order By: Relevance
“…[9][10][11]15,19 However, advances in the field have been confounded by the lack of reactive groups within the elastomer. Novel chemical syntheses developed by our group showed the feasibility of covalently …”
Section: Intravascular Adenovirus Implants Sj Stachelek Et Almentioning
confidence: 99%
See 4 more Smart Citations
“…[9][10][11]15,19 However, advances in the field have been confounded by the lack of reactive groups within the elastomer. Novel chemical syntheses developed by our group showed the feasibility of covalently …”
Section: Intravascular Adenovirus Implants Sj Stachelek Et Almentioning
confidence: 99%
“…[8][9][10] Initial studies showed that prosthetic heart valves composed of polyurethane with the anticalcification agent, bisphosphonate, covalently linked to the modified polyurethane surface was capable of resisting calcification beyond 5 months in an in vivo juvenile sheep model. [8][9][10] Although these first studies with modified polyurethane cardiovascular implants involved appending thiol-containing bisphosphonates in the form of a tetrabutylammonium salt, any thiol-containing moiety could theoretically be covalently attached to the bromoalkylated polyurethane surface. This makes feasible the use of polyurethane as a delivery platform for gene therapy vectors.…”
Section: Intravascular Adenovirus Implantsmentioning
confidence: 99%
See 3 more Smart Citations